Aurora-A/FOXO3A/SKP2 axis promotes tumor progression in clear cell renal cell carcinoma and dual-targeting Aurora-A/SKP2 shows synthetic lethality
Abstract Renal cell carcinoma (RCC) is a common malignant tumor in the world. Histologically, most of RCC is classified as clear cell renal cell carcinoma (ccRCC), which is the most prevalent subtype. The overall survival of patients with ccRCC is poor, thus it is urgent to further explore its mecha...
Main Authors: | Pu Li, Tingting Chen, Peng Kuang, Fujun Liu, Zhongmin Li, Fangfang Liu, Yu Wang, Wenfeng Zhang, Xiuyu Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-07-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-022-04973-9 |
Similar Items
-
Skp2 and Skp2B team up against Rb and p53
by: Germain Doris
Published: (2011-01-01) -
Inhibition of Skp2 Sensitizes Chronic Myeloid Leukemia Cells to Imatinib
by: Chen X, et al.
Published: (2020-06-01) -
Skp2 stabilizes Mcl-1 and confers radioresistance in colorectal cancer
by: Xinfang Yu, et al.
Published: (2022-03-01) -
Emerging Roles of SKP2 in Cancer Drug Resistance
by: Ting Wu, et al.
Published: (2021-05-01) -
Skp2 modulates proliferation, senescence and tumorigenesis of glioma
by: Juan Wu, et al.
Published: (2020-03-01)